Daniel Loeb
Third Point
Third Point 13F holdings
Daniel Loeb's Portfolio
- Portfolio value:
- $5.53B~
- # of securities:
- 61 (+3)
- Reported for:
- 30 Sep 2022 (Q3)
- Latest filing date:
- 14 Nov 2022
What was Daniel Loeb's 2022 Q3 portfolio?
Third Point has disclosed a total of 61 security holdings in their (2022 Q3) SEC 13F filing(s) with portfolio value of $5,534,759,000.
Third Point's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Daniel Loeb's original 13F reports (2022 Q3) are the official SEC institutional disclosure documents covering all reported equity positions.
59 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Colgate-Palmolive Company
|
14.66%
|
11,550,000
|
$70.25
|
+29.13%($90.72)
|
$811,388,000
|
2022 Q2
|
~0.50 years
|
+481.86% (+9.56M)
|
+12.14%
|
|
|
|
PG&E Corp
|
14.32%
|
63,400,000
|
$12.50
|
+30.76%($16.34)
|
$792,500,000
|
2020 Q3
|
~2.25 years
|
-3.06% (-2M)
|
-0.59%
|
|
|
|
Danaher Corp
|
12.60%
|
2,700,000
|
$258.29
|
-16.43%($215.85)
|
$697,383,000
|
2015 Q3
|
~7.25 years
|
+17.39% (+400K)
|
+1.87%
|
|
|
|
SentinelOne Inc
|
8.77%
|
19,000,000
|
$25.56
|
-17.19%($21.16)
|
$485,640,000
|
2021 Q2
|
~1.50 years
|
-9.86% (-2.08M)
|
-1.26%
|
|
|
|
UnitedHealth Group Incorporated
|
6.11%
|
670,000
|
$505.04
|
-21.86%($394.64)
|
$338,377,000
|
2020 Q4
|
~2.00 years
|
+17.54% (+100K)
|
+0.91%
|
|
|
|
Bath & Body Works Inc
|
4.79%
|
8,135,000
|
$32.60
|
-40.61%($19.36)
|
$265,201,000
|
2022 Q3
|
~0.25 years
|
new
|
+4.79%
|
|
|
|
Twitter Inc
|
4.36%
|
5,500,000
|
$43.84
|
|
$241,120,000
|
2022 Q3
|
~0.25 years
|
new
|
+4.36%
|
|
|
|
Ovintiv Inc
|
3.32%
|
4,000,000
|
$46.00
|
+40.03%($64.42)
|
$184,000,000
|
2022 Q1
|
~0.75 years
|
-34.64% (-2.12M)
|
-2.31%
|
|
|
|
Ventyx Biosciences Inc
|
2.72%
|
4,312,834
|
$34.91
|
|
$150,561,000
|
2021 Q4
|
~1.00 year
|
|
|
|
|
|
EQT Corp
|
2.39%
|
3,250,000
|
$40.75
|
+34.45%($54.79)
|
$132,438,000
|
2021 Q4
|
~1.00 year
|
-56.81% (-4.28M)
|
-4.12%
|
|
Completely sold out
8 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Cenovus Energy Inc
|
-7,275,000
|
-3.27%
|
2022 Q1
|
~0.50 years
|
|
|
|
Crown Holdings Inc
|
-800,000
|
-1.75%
|
2021 Q4
|
~0.75 years
|
|
|
|
Archaea Energy Inc
|
-3,465,000
|
-1.27%
|
2021 Q1
|
~1.50 years
|
|
|
|
GO Acquisition Corp
|
-3,000,000
|
-0.71%
|
2021 Q1
|
~1.50 years
|
|
|
|
Soho House & Co Inc
|
-3,470,194
|
-0.53%
|
2021 Q3
|
~1.00 year
|
|
|
|
Social Leverage Acquisition Corp I, CL-A
|
-1,000,000
|
-0.23%
|
2021 Q2
|
~1.25 years
|
|
|
|
FAR PEAK ACQ, CL-A -CW25
|
-666,666
|
-0%
|
2021 Q1
|
~1.50 years
|
|
|
|
GO ACQUISITION CORP -CW27GO
|
-1,000,000
|
-0%
|
2021 Q1
|
~1.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".
* % of portfolio: the total can exceed 100%, e.g. when there are also options positions, which can be short.